As of September 29, 2022, more than 6.1 million people in Israel received two doses of the coronavirus (COVID-19) vaccine. Of these, nearly 73 percent got an additional third dose, the so-called booster shot. In addition, people can receive a second booster shot (fourth shot) if they want to, or a specific vaccine that is suitable for the Omicron variants.

The number of COVID-19 vaccination doses administered per 100 people in Israel rose to 197 as of Oct 27 2023. This dataset includes a chart with historical data for Israel Coronavirus Vaccination Rate.

As of December 23, 2022, around 80 percent of the population of the United States had been given at least one dose of a COVID-19 vaccination. This statistic shows the percentage of population in select countries and territories worldwide that had received a COVID-19 vaccination as of December 23, 2022.

Immunization, measles (% of children ages 12-23 months) in Israel was reported at 98 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Israel - Immunization, measles (% of children ages 12-23 months) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

As of March 20, 2023, around 391 doses of COVID-19 vaccines per 100 people in Cuba had been administered, one of the highest COVID-19 vaccine dose rates of any country worldwide. This statistic shows the rate of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country or territory.

Israel: Percent of one-year-old children with Hepatitis B immunization: The latest value from 2022 is 96 percent, unchanged from 96 percent in 2021. In comparison, the world average is 85 percent, based on data from 183 countries. Historically, the average for Israel from 1992 to 2022 is 96 percent. The minimum value, 92 percent, was reached in 1992 while the maximum of 99 percent was recorded in 2004.

Immunization, HepB3 (% of one-year-old children) in Israel was reported at 96 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Israel - Immunization, HepB3 (% of one-year-old children) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

We propose a new approach to estimate the vaccination rates required to achieve herd immunity against SARS-COV2 virus at a city level. Based on information obtained from the Israeli Ministry of Health, we estimate two separate quadratic models, one for each dose of the BNT162b2 mRNA Pfizer vaccine. The dependent variable is the scope of morbidity, expressed as the number of cases per 10,000 persons. The independent variables are the first and second vaccination rates and their squares. The outcomes corroborate that herd immunity is achieved in the case that 71 percent of the urban population is vaccinated, and the minimum anticipated scope of morbidity is approximately 5 active COVID-19 cases per 10,000 persons, compared to 53–67 cases per 10,000 persons for zero vaccination rate. Findings emphasize the importance of vaccinations and demonstrate that urban herd immunity may be defined as a situation in which people continue to interact, yet the COVID-19 spread is contained. This, in turn, might prevent the need for lockdowns or other limitations at the city level.

Immunization, Hib3 (% of children ages 12-23 months) in Israel was reported at 98 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Israel - Immunization, Hib3 (% of children ages 12-23 months) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.